✦ LIBER ✦

996 ORAL Randomized phase III study in squamous cell carcinoma of the head & neck (SCCHN) using lipoplatin: First safety results of a multicenter trial

Book ID: 118623572
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 273 KB
Volume: 3
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(05)81291-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O167 First safety and response results o

O167 First safety and response results of a randomized Phase III study with liposomal platin in the treatment of advanced squamous cell carcinoma of the head & neck (SCCHN)

✍ Jehn, C.; Siepmann, S.; Pecher, G.; Wernecke, K.D.; Possinger, K.; Lüftner, D. 📂 Article 📅 2007 🏛 Elsevier Science ⚖ 51 KB

5501 ORAL Cetuximab plus platinum-based

5501 ORAL Cetuximab plus platinum-based therapy first-line in recurrent and/or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Efficacy and safety results of a randomized phase III trial (EXTREME)

✍ Vermorken, J.B.; Hitt, R.; Geoffrois, L.; Erfan, J.; Kawecki, A.; Zabolotnyy, D. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Alternating chemoradiotherapy versus par

Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck : Results from a phase III randomized trial

✍ Renzo Corvò; Marco Benasso; Giuseppe Sanguineti; Rita Lionetto; Almalina Bacigal 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 1 views

## BACKGROUND. The authors previously have found that in patients with locally advanced squamous cell carcinoma of the head and neck (SCC-HN), alternating chemoradiotherapy (ALT) was superior to low-total-dose conventional radiotherapy alone. The purpose of this randomized trial was to compare the

8516 A phase 2 randomized trial of radio

8516 A phase 2 randomized trial of radiotherapy (RT) plus panitumumab compared to chemoradiotherapy in patients with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): interim pooled safety analysis

✍ Giralt, J.; Trigo, J.M.; Nuyts, S.; Ozsahin, M.; Markowitz, A.B.; Daisne, J.; Sk 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Neoadjuvant chemotherapy with cisplatin

Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized Phase III study

✍ Freddi Lewin; Lena Damber; Håkan Jonsson; Torsten Andersson; Anne Berthelsen; An 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 587 KB

Mature results of a Phase III randomized

Mature results of a Phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with Stage III and IV squamous cell carcinoma of the head and neck

✍ David J. Adelstein; Pierre Lavertu; Jerrold P. Saxton; Michelle Secic; Benjamin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 3 views

The current study presents mature results from a Phase III randomized trial comparing radiation therapy and concurrent chemoradiotherapy in patients with resectable American Joint Committee on Cancer Stage III and IV disease.